Tomas Van Dyck

Tomas Van Dyck is an experienced finance executive currently serving as Chief Financial Officer at DeuterOncology NV and AbolerIS Pharma, and Co-Chief Executive Officer at 2 Bridge. With a career spanning over a decade, notable past roles include Finance Director at Vanas Engineering nv, Chief Finance Officer at Arseus Medical, and Financieel & Administratief Directeur at Indaver België. Academic credentials include an Executive Masterclass in Corporate Finance from Vlerick Business School, an International Executive Program from INSEAD, and a Master's degree in Business/Managerial Economics from KU Leuven.